Company: EDSA
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001171843-25-002028
Chunk: 3

Company: Edesa Biotech, Inc.
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 3
---
 not receive printed copies of the proxy materials unless they request them. Instead, instructions on how to access the proxy materials over the Internet or to request a printed copy may be found in the Internet Availability Notice. All shareholders will have the ability to access the proxy materials on the Website referred to in the Internet Availability Notice or request to receive a printed or electronic set of the proxy materials. Shareholders may request to receive proxy materials in printed form or electronically by email, by telephone, mail or by logging on to http://www.proxyvote.com/. We encourage shareholders to take advantage of the availability of proxy materials on the Internet to help reduce the environmental impact of our annual meetings.

How can I get electronic access to the proxy materials?

The Internet Availability Notice will provide you with instructions regarding how to:

| ● | View our proxy materials for the Annual Meeting on the Internet; and |

| ● | Instruct us to send future proxy materials to you electronically by email. |

Choosing to receive future proxy materials by email will reduce our costs of printing and mailing documents to you, which will favorably impact the environment. If you choose to receive future proxy materials by email, you will receive an email message next year with instructions containing a link to those materials. Your election to receive proxy materials by email will remain in effect until you terminate it.

<div align='center'>1</div>

Why are we calling this Annual Meeting?

We are calling the Annual Meeting to seek the approval of our shareholders:

| 1. | To elect seven (7) directors, nominated by our Board, to serve until our annual meeting of shareholders to be held in 2026 or until their successors are duly elected and qualified;                                                                                                                                                                                                |
| 2. | To approve, on an advisory basis, the executive compensation of our named executive officers as described in this proxy statement;                                                                                                                                                                                                                                                  |
| 3. | To approve an amendment to our 2019 Equity Incentive Compensation Plan (the “2019 Plan”) to (i) increase the number of shares available for issuance under the 2019 Plan by 1,725,000 shares, (ii) remove the 2019 Plan’s “fungible share pool” provisions and (iii) increase the number of shares issuable under the 2019 Plan as incentive stock options from 171,429 to 300,000; |
| 4. | To appoint MNP LLP as our auditors and independent registered public accounting firm for the fiscal year ending September 30, 2025;